Two Tests with Same Reference [Design Issues]

posted by Noha Abdeljawad – Cairo, Egypt, 2012-11-27 09:18 (4961 d 21:21 ago) – Posting: # 9598
Views: 27,529

Dear All,
In the bioequivalence center I work in, we need to carry out a BE study for two generic drugs containing the same active ingridient in the same strength from two different manufacturers. Since they both require using the same reference drug, we thought we'd do one crossover study of 3 phases, with one week (washout period) between each phase and the next. On each phase, each of the volunteers took test1 (A), test2 (B) or reference (C). By the end of the study, each of the three products will be adminstered to each volunteer. Bioequivalence assessment will be based on comparing PK parameters of A with C and then of B with C.

Is it ok to use this study design?
How will this affect ANOVA analysis?
Is this design referred to as two-way or three-way?

Thanks

Best Regards
Noha Abdeljawad

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
434 visitors (0 registered, 434 guests [including 22 identified bots]).
Forum time: 07:39 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5